IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 15 filers reported holding IN8BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,434 | +7.9% | 78,302 | +59.8% | 0.00% | 0.0% |
| Q2 2023 | $75,460 | -21.6% | 49,000 | -33.8% | 0.00% | -33.3% |
| Q1 2023 | $96,200 | -43.7% | 74,000 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $170,940 | +14.7% | 74,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $149,000 | +2.1% | 74,000 | +23.3% | 0.00% | +33.3% |
| Q2 2022 | $146,000 | -29.8% | 60,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $208,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Voss Capital, LLC | 101,779 | $446,000 | 0.14% |
| B. Riley Financial, Inc. | 257,378 | $1,130,000 | 0.13% |
| Nantahala Capital Management | 373,169 | $1,638,000 | 0.06% |
| Sigma Planning Corp | 28,600 | $126,000 | 0.00% |
| Ensign Peak Advisors, Inc | 70,028 | $307,000 | 0.00% |
| Capital World Investors | 800,000 | $3,512,000 | 0.00% |
| MORGAN STANLEY | 1,928 | $8,000 | 0.00% |
| BlackRock Inc. | 9,561 | $42,000 | 0.00% |
| HighTower Advisors, LLC | 10,000 | $44,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,176 | $14,000 | 0.00% |